"When it comes to improving your vision and helping you live your best life, our team is ready to provide effective treatments and 100% satisfaction."

During the past decade, Southern California Eye Physicians and Associates conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Southern California Eye Physicians and Associates" are "Cataract" (4 trials), "Cataracts" (2 trials), "Astigmatism" (1 trials), "Corneal Astigmatism" (1 trials) and "Corneal Edema After Cataract Surgery" (1 trials). Many other conditions were trialed in "Southern California Eye Physicians and Associates" in a lesser frequency.

Most popular intervention types in "Southern California Eye Physicians and Associates" are "Device" (6 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "APP13007, 0.05%" (1 trials), "Control Healon EndoCoat" (1 trials), "Higher Cylinder Toric IOL" (1 trials), "Investigational Healon Endocoat" (1 trials) and "Lower Cylinder Toric IOL" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southern California Eye Physicians and Associates" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Southern California Eye Physicians and Associates". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Southern California Eye Physicians and Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Southern California Eye Physicians and Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".